Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis

Cancer

Volumn 77, Issue 3, 1996, Pages 522-525

  Fidler, Pat ^a   Loprinzi, Charles L ^b   O'Fallon, Judith R ^b   Leitch, John M ^c   Lee, Jeraldine K ^b   Hayes, Debra L ^d   Novotny, Paul ^b   Clemens Schutjer, Danette ^e,f   Bartel, Joan ^g   Michalak, John C ^h  

^a CREIGHTON UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

^c MeritCare Hospital   (United States)

^d Clinical Oncology Program   (United States)

^e Iowa Oncology Research Association Community Clinical Oncology Program   (United States)

^f Interventional Radiology Section of Radiologists of North Iowa   (United States)

^g Allan Blair Cancer Centre   (Canada)

^h Siouxland Hematology Oncology Associates   (United States)

Author keywords

Chamomile; Chemotherapy toxicity; Mucositis; Stomatitis; Symptom control study

Indexed keywords

CHAMOMILE; FLUOROURACIL; PLACEBO;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOTHERAPY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH HYGIENE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STOMATITIS;

ANTIMETABOLITES, ANTINEOPLASTIC; CHAMOMILE; DOUBLE-BLIND METHOD; FEMALE; FLAVONOIDS; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MOUTHWASHES; OILS, VOLATILE; PLANTS, MEDICINAL; STOMATITIS;

EID: 0030058169     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960201)77:3<522::AID-CNCR14>3.0.CO;2-6     Document Type: Article

References (17)

1. Mahood DJ, Dose AM, Loprinzi CL, Veeder MH, Athmann LM, Therneau TM, et al. Inhibition of 5-fluorouracil-induced mucositis by oral cryotherapy. J Clin Oncol 1991;9:449-52.
2. Rocke LK, Loprinzi CL, Lee JK, Kunselman SJ, Iverson RK, Finck G, et al. A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis. Cancer 1993;72(7):2234-8.
3. Isaac O. Advances in chamomile research. Deutsche Apotheker-Zeitung 1974;114(7):155-260.
4. Craker LC and Simon JE. Herbs, spices, and medicinal plants: recent advances in botany, horticulture, and pharmacology. vol. 1 Oryx Press, 1986.
5. Aggag ME and Yousef RT. Study of antimicrobial activity of chamomile oil. PLMEAA 1972;22(2):109-212.
6. Della Loggia R. Topical anti-inflammatory action of the chamomile flovones. Duetsche Apotheker-Zeitung, (I Suppl):9-11.
7. Klaschka F, Maiwald L, Patzelt-Wenczler R. Chamomile: mode of action and formulations. Interdiscipolinary Chamomile Symposium; 1987; Frankfurt/Main, West Germany.
8. Carl W, Emrich LS. Management of oral mucositis during local radiation and systemic chemotherapy: a study of 98 patients. J Prosthet Dent 1991;66:361-9.
9. Loprinzi CL, Cianflone SG, Dose AM, Etzell PS, Burnham NL, Therneau TM, et al. A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis. Cancer 1990;65(8):1879-82.
10. Ferrara JM, Mattem JQUH. Sucralfate suspension for stomatitis [letter]. Drug Intelligence and Clinical Pharmacy 1984;18:153.
11. Shenep JL, Kalwinsky DK, Hutson PR, George SL, Dodge RK, Blonkenship KR, et al. Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mucositis. J Pediatr 1988;4:113,758-63.
12. Wadleigh R, Redman R, Cohen M, Krasnow S, Anderson A, Graham M. Vitamin E in the treatment of chemotherapy-induced mucositis. Proc ASCO 1990;9:1237.
13. Kim JE, Shklar G. The effect of vitamin E on the healing of gingival wounds in rats. J Periodontol 1983;54:305-8.
14. Anderson PM, Skubitz KM. Oral glutamine suspension to ameliorate chemotherapy induced mucositis [abstract]. ASPHO Proc 1993;2:32.
15. Fox AD, Kripke SA, De Paula J, Berman JM, Settle RG, Rombeau JL. Effect of a glutamine-supplemented enteral diet on methotrexate-induced enterocolitis. J Parenter Enter Nutr 1988;12(4):325.
16. Spijkervet F, Vermey A, Panders A, Saene H, Mehta D. Prevention of irradiation mucositis in head-neck cancer patients. Proc ASCO 1990;9:174.
17. Kaanders JHAM, Pop LAM, Uitterhoeve RJ, van Daal WAJ. Prevention of irradiation mucositis in the oral cavity and oropharynx by PTA-lozenges. Int J Radiat Oncol Biol Phys 1993;1 Suppl 27:253.